东曜药业股份有限公司（股票代码：01875）于2026年4月9日发布截至2026年3月31日的股份变动月报表。公告显示，公司本月法定或注册股本无变化。
根据公告披露，截至3月31日，公司已发行股份（不含库存股）仍为772,787,887股，与上月持平。报告期内未发生新增发行、回购、注销或库藏股变动。
在股权激励方面，公司已有的股份期权计划合计7,632,600股期权，本月期间未出现授出、行使或失效，期末结存数量不变。
公司强调已遵守香港联交所《上市规则》及相关法律规定。该月报表由联席公司秘书吕颖一签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.